Complete Genomics

Human Identification Market Worth $1.3 billion | MarketsandMarkets™

Retrieved on: 
Martedì, Aprile 16, 2024
Pulse, Investment, Promega, Competition, QIAGEN, Complete Genomics, Research, Growth, South Korea, Criminology, DNA, Thermo Fisher Scientific, Government, Market development, Risk management

The break-up of the profile of primary participants in the human identification market:

Key Points: 
  • The break-up of the profile of primary participants in the human identification market:
    Get 10% Free Customization on this Report:
    Human Identification Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall human identification market and the subsegments.
  • The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the human identification market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the human identification market across varied regions.

Human Identification Market Worth $1.3 billion | MarketsandMarkets™

Retrieved on: 
Martedì, Aprile 16, 2024
Pulse, Investment, Promega, Competition, QIAGEN, Complete Genomics, Research, Growth, South Korea, Criminology, DNA, Thermo Fisher Scientific, Government, Market development, Risk management

The break-up of the profile of primary participants in the human identification market:

Key Points: 
  • The break-up of the profile of primary participants in the human identification market:
    Get 10% Free Customization on this Report:
    Human Identification Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall human identification market and the subsegments.
  • The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the human identification market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the human identification market across varied regions.

Complete Genomics and seqWell Announce Codevelopment Partnership at AGBT

Retrieved on: 
Mercoledì, Febbraio 7, 2024
Partnership, Genomics, Product management, SAN, Marketing, Complete Genomics, Completeness, Human genetics, DNA, Mass meeting, Society, NGS, Genomic library, Synthetic biology, ASHG

SAN JOSE, Calif. and BEVERLY, Mass., Feb. 7, 2024 /PRNewswire/ -- Complete Genomics, a life sciences company specializing in end-to-end DNA sequencing solutions, and seqWell, a global provider of genomic library preparation workflow solutions, today announced a partnership aimed at expanding the range of library preparation product offerings available to Complete Genomics customers. The companies will work together to ensure seqWell-developed products are compatible with the entire Complete Genomics next-generation sequencing (NGS) and automation portfolios.

Key Points: 
  • The companies will work together to ensure seqWell-developed products are compatible with the entire Complete Genomics next-generation sequencing (NGS) and automation portfolios.
  • "Our partnership with seqWell enables us to offer a broader range of tools to support a broader range of customer needs."
  • Leveraging the power of the Complete Genomics DNBSEQ-G400RS * and seqWell purePlex ™ DNA Library Prep Kit , this partnership will allow customers to the ability to run cost-effective and scalable workflows pairing seqWell library prep kits with Complete Genomics' portfolio of DNBSEQ technologies.
  • The latest outcome of this partnership enables customers to pair seqWell's ExpressPlex ™ library prep kits with Complete Genomics' portfolio of DNBSEQ technologies, including the DNBSEQ-G-99 RS* and DNBSEQ-T7 RS* sequencers.

At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer

Retrieved on: 
Martedì, Febbraio 6, 2024
Genomics, Metagenomics, SAN, Complete Genomics, Research, Mass meeting, CMOS, Environmental monitoring, Chemistry, MPS, HLA, Software, MRD, Standard, Q50, Genome, Antibiotics

SAN JOSE, Calif., Feb. 6, 2024 /PRNewswire/ -- Complete Genomics, a California-based life sciences company that provides novel, comprehensive sequencing solutions, today highlighted expanded sequencing applications enabled by DNBSEQ™-T7, a leading high- throughput sequencer which will be the subject of customer talks at the Advances in Genome Biology and Technology (AGBT) General Meeting.

Key Points: 
  • After four years in the field, the DNBSEQ-T7, or the T7, remains a leading sequencer in its class, due to its speed, accuracy and flexibility.
  • The T7 enables a wide range of applications such as CompleteWGS, a novel phased genome approach, spatial transcriptomics, cf-DNA sequencing for MRD and early detection, and single cell sequencing.
  • The DNBSEQ™-T20X2 is Complete Genomics' ultra-high-throughput sequencer for the most challenging projects, delivering efficient sequencing at less than $1 per Gigabase.
  • Highly accurate base calling and robust copy number correction is ensured by our robotics-enabled fluidics, which uses whole-wafer-sized slides.

MGI Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research

Retrieved on: 
Martedì, Gennaio 30, 2024
Transfer, Research, COVID, Complete Genomics, Medicine, Genomics, Laboratory, Microfluidics, PCR, Automation, MGI, Microbiology, Fine chemical

SHENZHEN, China, Jan. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. (referred to as MGI), a leading provider of cutting-edge tools and technology for life science and healthcare research, today announced a strategic expansion of its automation product lines. This expansion covers sample pretreatment, sample preparation and integrated testing, leveraging its innovative technologies and expertise in genetic sequencing and multi-omics.

Key Points: 
  • SHENZHEN, China, Jan. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. (referred to as MGI), a leading provider of cutting-edge tools and technology for life science and healthcare research, today announced a strategic expansion of its automation product lines.
  • MGI's automation product lines aim to address the growing demand for high-throughput, efficient and reliable solutions in precision medicine, precision agriculture, precision healthcare and related industries.
  • MGI's expansion of automation product lines emphasizes its commitment to intelligent innovation in life sciences, and providing advanced tools that enhance efficiency, accuracy, and research turnaround times.
  • "MGI is proud to announce the expansion of our automation product lines, providing advanced solutions to our life science and healthcare partners.

Complete Genomics and Gencove Announce agreement at Plant and Animal Genome Conference (PAG 31) to offer a bundled solution for low-pass whole genome sequencing

Retrieved on: 
Martedì, Gennaio 16, 2024
Entrepreneurship, Research, SAN, DNA, Partnership, Whole genome sequencing, GWAS, Complete Genomics, Genomics, Genome, Antibiotics

The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilities via high-throughput nucleic acid extraction, automated library preparation on its DNBSEQ-T7RS* and DNBSEQ-T20X2RS* sequencers.

Key Points: 
  • The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilities via high-throughput nucleic acid extraction, automated library preparation on its DNBSEQ-T7RS* and DNBSEQ-T20X2RS* sequencers.
  • "While low-pass whole genome sequencing has long been touted as an advanced method for everything from GWAS analysis to genotyping for molecular breeding, its potential hasn't been fully realized.
  • "Through this partnership with Complete Genomics, we're enabling higher throughput results at a lower cost per sample, making more affordable sequencing accessible to more researchers," said Joseph Pickrell, Ph.D., co-founder, and CEO of Gencove.
  • "It will provide the kind of comprehensive genome coverage that leads to the discovery of novel variants."

Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters

Retrieved on: 
Giovedì, Novembre 16, 2023
Foot, International Organization (journal), WGS, Research, SAN, Engineering, Entrepreneurship, Integrated DNA Technologies, Completeness, Base pair, ISO, Complete Genomics, Genomics, Integration, Biotechnology

SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California.

Key Points: 
  • SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California.
  • The facility, scheduled to open in March 2024, will give Complete Genomics customers access to a U.S.-based supply chain translating into faster delivery times for its next generation sequencing products.
  • The new facility will house Complete Genomics' research and development, engineering and ISO (International Organization for Standardization) manufacturing operations.
  • In May 2017, Complete Genomics moved to its current 78,979 square foot location in San Jose, which also includes a warehousing facility.

Complete Genomics' DNBSEQ-T20x2RS* Named "Next Generation Sequencing Solution of the Year" by 2023 BioTech Breakthrough Awards Program

Retrieved on: 
Mercoledì, Novembre 8, 2023
Complete Genomics, Genome, Genomics, Entrepreneurship, Biotechnology, SAN, Pharmaceutical industry, Antibiotics

SAN JOSE, Calif., Nov. 8, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced it is the recipient of the 2023 "Next Generation Sequencing Solution of the Year" award in the third annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, an independent market intelligence organization that evaluates and recognizes life sciences and biotechnology companies, products and services around the globe.

Key Points: 
  • SAN JOSE, Calif., Nov. 8, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced it is the recipient of the 2023 "Next Generation Sequencing Solution of the Year" award in the third annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough , an independent market intelligence organization that evaluates and recognizes life sciences and biotechnology companies, products and services around the globe.
  • Complete Genomics' unveiling of its DNBSEQ-T20x2RS* in 2023 marked the first time in the industry that a high throughput sequencer reduced the price of genome sequencing to less than $100, or less than $1 per gigabyte.
  • Using two-color sequencing, DNBSEQ-T20x2RS* saves 50% of optical, computing, storage and broadband resources compared to four-color technology, which contributes to significant cost savings.
  • The mission of the annual BioTech Breakthrough Awards program is to conduct the industry's most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today.

Complete Genomics and Basepair™ Announce Technology Integration Partnership

Retrieved on: 
Giovedì, Novembre 2, 2023
Complete Genomics, Knowledge, Genomics, Amazon Web Services, NGS, Partnership, Workflow, AWS, Marketing, SAN, Completeness, Cryptocurrency, Antibiotics, Base pair

SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*.

Key Points: 
  • SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*.
  • The partnership gives Complete Genomics' customers the ability for seamless access to Basepair's bioinformatics platform deployed on Amazon Web Services (AWS) and use its easy-to-use point & click user interface to launch and orchestrate NGS workflows in the cloud, either by provisioning in their own accounts or via Basepair's hosted service.
  • "Our partnership with Basepair is another way for Complete Genomics to make our customer experience more seamless at all stages of the NGS workflow," Tarbox said.
  • "It's long been the holy grail of genomics to deliver a seamless sample to answer experience for scientists and clinicians," Basepair's CEO & Founder, Amit Sinha, said.

Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.

Retrieved on: 
Martedì, Ottobre 31, 2023
Complete Genomics, ASHG, RNA-Seq, Nebula Genomics, Karkus, G400, Whole genome sequencing, IDT, Medical laboratory, Bio-Rad Laboratories, RNA, University of Massachusetts, Face, Professor, Research, SNP, Society, American Society of Human Genetics, Ecosystem, Partnership, WGS, Human genetics, Google AI, Sequoia, Integrated DNA Technologies, Automation, New England Biolabs, Integration, New England, Completeness, Stanford University School of Medicine, Antibiotics, Medical device, Genomics

At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.

Key Points: 
  • At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.
  • See the full description of speakers Complete Genomics is bringing to ASHG at completegenomics.com/ashg-2023-event-page .
  • Based in San Jose, CA, Complete Genomics celebrated its U.S. commercial launch of its DNBSEQ™ sequencing product line one year ago at ASHG 2022.
  • "Our collaboration with Complete Genomics underscores our commitment to providing researchers with advanced solutions for sequencing applications."